GreenLight Biosciences Accounts Payable

GreenLight Biosciences (GRNA) currently reports a accounts payable of $1.1M as of March 2023. That compares with $6M in the prior-year period — down 82.3% year over year. Use the charts on this page to explore GreenLight Biosciences's accounts payable history and peer comparisons.

GreenLight Biosciences's accounts payable decreased from $6M to $1.1M — a 82.3% year-over-year decrease (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GreenLight Biosciences reported $1.1M in accounts payable as of March 2023. That compares with $6M in the prior-year period — down 82.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $1.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GreenLight Biosciences, and consider following GRNA for alerts when major investors trade the stock.